STERIS plc Cost of Revenue
STERIS plc (STE) reported Cost of Revenue of $3.31 billion for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-29.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-05-29
- STERIS plc cost of goods and services sold for the quarter ending 2024-03-31 was $836.49M, a 13.83% increase year-over-year.
- STERIS plc cost of goods and services sold for the quarter ending 2023-12-31 was $737.70M, a 16.31% increase year-over-year.
- STERIS plc cost of goods and services sold for the quarter ending 2023-09-30 was $691.98M, a 13.69% increase year-over-year.
- STERIS plc cost of goods and services sold for the quarter ending 2023-06-30 was $654.38M, a 13.25% increase year-over-year.
- STERIS plc cost of goods and services sold for fiscal 2026 was $3.31B, a 8.26% increase from fiscal 2025.
- STERIS plc cost of goods and services sold for fiscal 2025 was $3.06B, a 4.67% increase from fiscal 2024.
- STERIS plc cost of goods and services sold for fiscal 2024 was $2.92B, a 14.28% increase from fiscal 2023.
- STERIS plc cost of goods and services sold for fiscal 2023 was $2.56B, a 9.19% increase from fiscal 2022.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.31B 10-K · filed 2026-05-29 | |||||
| 2025-03-31 | $3.06B 10-K · filed 2026-05-29 | $3.06B 10-K · filed 2025-05-29 | ||||
| 2024-03-31 | $836.49M 10-K · filed 2024-05-29 | $1.57B derived: sum of 2 quarters · filed 2024-05-29 | $2.27B derived: sum of 3 quarters · filed 2024-05-29 | $2.92B 10-K · filed 2026-05-29 | $2.92B 10-K · filed 2024-05-29 | |
| 2023-12-31 | $737.70M 10-K · filed 2024-05-29 | $1.43B derived: sum of 2 quarters · filed 2024-05-29 | $2.08B derived: sum of 3 quarters · filed 2024-05-29 | $2.82B derived: sum of 4 quarters · filed 2024-05-29 | ||
| 2023-09-30 | $691.98M 10-K · filed 2024-05-29 | $1.35B derived: sum of 2 quarters · filed 2024-05-29 | $2.08B derived: sum of 3 quarters · filed 2024-05-29 | $2.72B derived: sum of 4 quarters · filed 2024-05-29 | ||
| 2023-06-30 | $654.38M 10-K · filed 2024-05-29 | $1.39B derived: sum of 2 quarters · filed 2024-05-29 | $2.02B derived: sum of 3 quarters · filed 2024-05-29 | $2.63B derived: sum of 4 quarters · filed 2024-05-29 | ||
| 2023-03-31 | $734.85M 10-K · filed 2024-05-29 | $1.37B derived: sum of 2 quarters · filed 2024-05-29 | $1.98B derived: sum of 3 quarters · filed 2024-05-29 | $2.56B 10-K · filed 2025-05-29 | $2.80B 10-K · filed 2023-05-26 | |
| 2022-12-31 | $634.24M 10-K · filed 2024-05-29 | $1.24B derived: sum of 2 quarters · filed 2024-05-29 | $1.82B derived: sum of 3 quarters · filed 2024-05-29 | |||
| 2022-09-30 | $608.63M 10-K · filed 2024-05-29 | $1.19B derived: sum of 2 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $577.82M 10-K · filed 2024-05-29 | $638.69M 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | $2.34B 10-K · filed 2024-05-29 | $2.57B 10-K · filed 2022-05-31 | ||||
| 2021-06-30 | $542.14M 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | $1.76B 10-K · filed 2023-05-26 | |||||
| 2020-03-31 | $458.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $901.77M derived: sum of 2 quarters · filed 2022-05-31 | $1.32B derived: sum of 3 quarters · filed 2022-05-31 | $1.71B 10-K · filed 2022-05-31 | ||
| 2019-12-31 | $442.91M 10-Q · filed 2020-02-10 | $861.08M derived: sum of 2 quarters · filed 2020-02-10 | $1.25B 10-Q · filed 2020-02-10 | |||
| 2019-09-30 | $418.17M 10-Q · filed 2019-11-07 | $809.13M 10-Q · filed 2019-11-07 | ||||
| 2019-03-31 | $433.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $843.18M derived: sum of 2 quarters · filed 2021-05-28 | $1.24B derived: sum of 3 quarters · filed 2021-05-28 | $1.61B 10-K · filed 2021-05-28 | ||
| 2018-12-31 | $409.24M 10-Q · filed 2020-02-10 | $803.54M derived: sum of 2 quarters · filed 2020-02-10 | $1.17B 10-Q · filed 2020-02-10 | |||
| 2018-09-30 | $394.30M 10-Q · filed 2019-11-07 | $764.00M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |